Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi(Teikyo University), Takeharu Yamanaka(National Cancer Center Hospital East), Hiroya Taniguchi(National Cancer Center Hospital East), Kinichi Hotta(Shizuoka Cancer Center), Takako Eguchi Nakajima(St. Marianna University School of Medicine), Yukihide Kanemitsu(National Cancer Center), Hiroyuki Uetake(National Hospital Organization), Kenjiro Kotake(Tokyo Medical and Dental University), Kentaro Yamazaki(Shizuoka Cancer Center), Naohiko YAMAGUCHI(Seirei Sakura Citizen Hospital), Toshiaki Tanaka(National Center For Child Health and Development), Michio Itabashi(Tokyo Women's Medical University), Keiji Sano(Osaka National Hospital), Yusuke Kinugasa(The Japanese Society of Gastroenterological Surgery), Keiji Matsuda(Teikyo University), Yoichi Ajioka(Niigata University), Hideki Ueno(National Defense Medical College), Kiyoshi Hasegawa(Bunkyo University), Takayuki Yoshino(University of Tsukuba), Akihito Tsuji(Kagawa University Hospital), Kentaro Sakamaki(Yokohama City University), Kei Muro(Aichi Cancer Center), Keiko Nemoto Murofushi(Tokyo Metropolitan Komagome Hospital), Yutaka Saitō(Kitasato University), Hirotoshi Kobayashi(Teikyo University Hospital), Megumi Ishiguro(Tokyo Medical and Dental University), Shinji Tanaka(Onomichi General Hospital), Hideyuki Ishida(Tokyo Medical and Dental University), Yoshinori Ito(National Cancer Center Hospital East), Yasuhiro Shimada(Tokyo Metropolitan Komagome Hospital), Masahiro Yoshida(Jikei University School of Medicine), Keisuke Uehara(National Defense Medical College), Kenichi Sugihara(Toujinkai Hospital), Shigeki Yamaguchi(Saitama Medical University), Shiro Oka(Kyoto University), Soichiro Ishihara(University of Tokyo Hospital), Tetsuya Hamaguchi(National Cancer Center Hospital East)
Cited by 1,951
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k